Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aegis Spine is a privately held U.S. medical device company focused on spine, orthopedic, and minimally invasive technologies. The company markets a commercial portfolio of spinal implants and related devices spanning cervical, thoracolumbar, minimally invasive surgery, sacroiliac joint fusion, biologic bone graft substitute, and pectus repair applications. Its product family includes expandable lumbar systems, cervical interbody and plating systems, thoracolumbar fusion devices, SI joint fusion implants, and demineralized bone matrix offerings. Aegis presents itself as a physician-centric organization serving surgeons and distributors, with headquarters in Costa Mesa, California and a research and development presence previously highlighted in Irvine, California. The business appears to be revenue-generating and commercially active rather than a therapeutics-stage biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aegis Spine.